Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
0.1272
+0.0062 (5.12%)
At close: Mar 13, 2026, 4:00 PM EDT
0.1225
-0.0047 (-3.69%)
After-hours: Mar 13, 2026, 7:59 PM EDT
Propanc Biopharma Market Cap
Propanc Biopharma has a market cap or net worth of $1.92 million as of March 13, 2026.
Market Cap
1.92M
Enterprise Value
2.01M
1-Year Change
n/a
Ranking
Category
Stock Price
$0.13
Market Cap Chart
Since August 15, 2025, Propanc Biopharma's market cap has decreased from $36.20M to $1.92M, a decrease of -94.70%. That is a compound annual growth rate of -99.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 1.90M | -73.61% |
| Dec 31, 2025 | 7.20M | -80.11% |
| Aug 15, 2025 | 36.20M | - |
View and export this data all the way back to 2025. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ernexa Therapeutics | 2.55M |
| 60 Degrees Pharmaceuticals | 2.53M |
| Lyra Therapeutics | 2.34M |
| KALA BIO | 2.30M |
| Calidi Biotherapeutics | 2.28M |
| Scinai Immunotherapeutics | 2.24M |
| Bone Biologics | 2.19M |
| Onconetix | 1.95M |